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Summary. Suicide risk, as well as psychiatric disorder, has been repeatedly reported in the inter-
national literature as an important issue in the care of  individuals suffering from epilepsy. In this 
pilot study a sample comprising 103 patients with a diagnosis of  temporal lobe epilepsy, were 
collected from three clinics. The patients were administered the Beck hopelessness scale (BHS), 
the Beck depression inventory (BDI) and the Zung self-rating anxiety scale (SAS). Hopelessness 
has been identified as a construct linked to the prediction and the prevention of  suicide. Twenty-
six percent of  the epileptic patients had scores ≥ 9 on the BHS, suggesting that they should be 
evaluated for suicidal inclinations. These patients were significantly older by about 9 years and 
had higher levels of  depression and anxiety, but they did not differ in sex, age of  onset of  epi-
lepsy or in their responsiveness to medication. In the logistic regression analysis, a hopelessness 
score ≥ 9 was predicted by BDI depression scores and SAS anxiety scores taking into account 
sex, age and response to epileptic medications. Despite a number of  limitations, this pilot study 
adds support for the need for screening for suicide risk in patients with epilepsy. Both clinical 
and psychometric data should be part of  the evaluation of  the epileptic patient for psychiatric 
and suicidality assessment.
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Riassunto (Depressione, disperazione e rischio di suicidio tra i pazienti affetti da epilessia). Il rischio 
di suicidio, al pari dei disturbi psichiatrici, è stato più volte indicato dalla letteratura internazionale 
come un importante problema legato al trattamento dei pazienti affetti da epilessia. In questo studio 
pilota è stato creato un campione di 103 pazienti affetti da epilessia del lobo temporale, trattati pres-
so tre strutture. I pazienti hanno completato la Beck hopelessness scale (BHS), il Beck depression 
inventory (BDI) e la Zung self-rating anxiety scale (SAS). La disperazione è stata identificata come 
un costrutto utile nel predire e prevenire il suicidio. Il 26% dei pazienti ha ottenuto un punteggio 
BHS  ≥ 9, suggerendo che sarebbe indicato valutarli per le loro inclinazioni suicide. Questi pazienti 
sono significativamente più anziani di circa 9 anni e riportano livelli di depressione e ansia maggiori, 
ma non si differenziano per sesso, età di esordio della patologia e risposta alle terapie antiepilettiche. 
Nella analisi di regressione logistica, il punteggio elevato alla BHS (≥ 9) è predetto dai punteggi di 
depressione BDI e ansia SAS, tenendo in considerazione sesso, età e risposta alle terapie antiepilet-
tiche. Nonostante il numero di limitazioni, questo studio pilota supporta la necessità di programmi 
di screening diretti ai pazienti affetti da epilessia. Sia dati psicometrici, sia dati clinici debbono essere 
considerati nel processo di valutazione dei disturbi psichiatrici e del rischio di suicidio.
Parole chiavi: suicidio, disperazione, epilessia, depressione, ansia.
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INTRODUCTION
According to the World Health Organization [1], 
epilepsy is one of the most common serious disor-
ders of the brain, affecting about 50 million people 
worldwide. Epilepsy accounts for one percent of the 
global burden of disease. Eighty percent of this bur-
den is in the developing world where, in some areas, 
as many as 80-90% of people with epilepsy receive 
no treatment at all. 
It is important to recognize that epilepsy consists of 
more than seizures for the affected individual. Epilepsy 
results also in multiple, interacting, medical, psycho-
logical, economic and social repercussions, all of which 
need to be considered in order to understand fully the 
impact of this condition. Fear, misunderstanding and 
the resulting social stigma and discrimination sur-
rounding epilepsy often force people with this disorder 
“into the shadows”. The incidence (the number of new 
cases per year) of epilepsy is 24-53 per 100 000 per year 
in developed countries [2]. The prevalence (the total 
number of cases at a particular point in time) of active 
epilepsy has been shown to be fairly uniform at 4-10 
per 1000 people [3]. In developed countries, mortality 
in epileptics, measured by the standardized mortality 
ratio (SMR), is two to three times greater than that of 
the general population. 
Several studies have reported increased rates of ad-
justment problems and psychopathology [4-6]. Affective 
and anxiety disorders represent the most common co-
morbid disorders in epilepsy, although probably 
somewhat underestimated [7-12]. Common figures 
for depression in community-based studies are be-
tween 9-36% [13-16], while rates for hospitalized pa-
tients are generally higher, from 27% to 58% [17-19]. 
Depression significantly affects the quality of life and 
disability in people with epilepsy [16, 20, 21] and is a 
predictor of suicidal behavior.
Suicidal behavior in epileptics seems to be more 
frequent than that reported in the general population 
[22, 23], although some investigators have not found 
excess mortality due to this cause [24, 25]. However, 
the possibility of the underestimation of suicide risk 
among patients with epilepsy was stressed by a recent 
paper [26].
Figures reported are somewhat different from re-
searcher to researcher, and a possible estimate of 
risk could be around a five times greater than ex-
pected [27]. Five to fourteen percent of patients with 
epilepsy have attempted or committed suicide [28]. 
Nevertheless, the standard mortality rate for the 
various categories of patients with epilepsy varies 
greatly, which is indicative of the heterogeneity of 
the phenomenon. For example, Barraclough [29], 
reviewing the literature, estimated a suicide rate 25 
times greater than expected for temporal lobe epi-
lepsy and five times greater for severe epilepsy.
Several risk factors for suicide in epileptics have been 
identified. A number of studies have reported that an 
increased suicide rate was associated with temporal 
lobectomy [30, 31], resection in the left region with 
worsening of seizures, and right temporal resection 
that led to the emergence of psychotic symptoms and 
increased severity of seizures [32, 33]. Suppression of 
seizures or full control of seizures has also been iden-
tified as a possible risk factor for suicide [30, 34].
The age at onset is another variable to take into ac-
count. Risk of suicide is greatest when the epilepsy 
starts in adolescence and when it is combined with a 
history of psychiatric disturbance. In cases of institu-
tional care, suicide risk is also increased, possibly be-
cause of the severe handicaps in these patients [29]. 
Comorbidity with psychiatric disorders, mainly psy-
chosis and the presence of psychological stressors, are 
other risk factors [35, 36], especially post- and inter-ic-
tal psychopathology [25, 36]. For example, emergence 
of depression after surgical treatment among suicides 
was reported by Hennessy et al. [37] and Bladin [30]. 
Camfield et al. [31] reported that interictal dysphoric 
disorder, violent anger, and previous suicidal behav-
ior were detectable among suicides. 
This review of the literature indicates an increased risk 
of psychopathology and suicidal behaviour in epileptic 
patients and points to several risk factors for suicide. 
However, relevant studies are rare in Italian popula-
tion. The aim of the present research was to study the 
level of depression and hopelessness in patients with 
epilepsy. Since both depression and hopelessness predict 
subsequent suicidal behavior [38], the present study may 
throw some light on the risk of suicide in Italian epilep-
tic patients, where research is rare. 
MATERIALS AND METHODS
The sample comprised 103 patients suffering from 
temporal lobe epilepsy. Thirty patients were studied at 
the Neurological Clinic of I Faculty of Medicine, “La 
Sapienza” University of Rome; 40 patients were stud-
ied at the Regional Center for the Study of Epilepsy, 
Santa Maria della Misericordia Hospital, Perugia; 
and 33 patients were studied at the Department of 
Neurosciences Division of Psychiatry University of 
Parma. Overall, there were 72 females and 31 males. 
All the patients, consecutively admitted over a 6-
month period that met the inclusion/exclusion criteria, 
were asked to participate at the study. Inclusion criteria 
were a diagnosis of temporal lobe epilepsy, while ex-
clusion criteria were a current diagnosis of dementia 
or delirium, active psychotic symptoms (delusions and 
hallucinations), illiteracy or any conditions affecting 
the ability to complete the assessment, and a refusal to 
give informed consent. All the patients who were eligi-
ble voluntarily agreed to participate the study and were 
administered several self-rating measures. Our sample 
may be considered to be a good representation of the 
overall population of our centers. 
Table 1 reports the demographic and clinical char-
acteristics of patients.
The patients were administered the following in-
struments:
-  the Beck hopelessness scale [BHS] [39] is a 20-item 
scale for measuring negative attitudes about the fu-
ture. Beck originally developed this scale in order 
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to predict who would commit suicide and who 
would not. This powerful predictor of eventual 
suicide addressed three major aspects of hope-
lessness: feelings about the future, loss of moti-
vation, and expectations. Responding to the 20 
true-false items on the BHS, individuals can ei-
ther endorse a pessimistic statement or deny an 
optimistic statement. Research consistently sup-
ports a positive relationship between BHS scores 
and measures of depression, suicidal intent, and 
suicidal ideation. Beck, et al. [38] carried out a 
prospective study of 1958 outpatients evalu-
ated at the Center for Cognitive Therapy at the 
University of Pennsylvania School of Medicine, 
found that hopelessness, as measured by the BHS, 
was significantly related to eventual suicide. A 
cutoff  score of 9 or above identified 16 [94%] of 
the 17 patients who eventually committed suicide 
[38]. According to that study, the high-risk group 
identified by this cutoff  score was 11 times more 
likely to commit suicide than the rest of the out-
patients. The BHS may, therefore, be used as a 
proxy indicator of suicide potential. 
-  The Beck depression inventory [40, 41] [BDI, BDI-
II] is a twenty-one question multiple-choice self-
report inventory that is one of the most widely 
used instruments for measuring the severity of 
depression. The questionnaire is designed for 
adults aged 17-80 and is composed of items re-
lating to symptoms of depression such as hope-
lessness and irritability, cognitions such as guilt 
and feelings of being punished, as well as physi-
cal symptoms such as fatigue, weight loss and 
lack of interest in sex. There are three versions of 
the BDI: the original BDI, first published in 1961 
and later revised in 1971 as the BDI-1A, and the 
BDI-II, published in 1996 (used in this investiga-
tion). The BDI is widely used as an assessment 
tool by healthcare professionals and researchers 
in a variety of settings. A cut-off  higher than 9 
was used to ascertain at least minimal symptoms 
of depression.
-  The Zung self-rating anxiety scale [SAS] [42] is a 
20-item scale, with some of the items keyed posi-
tively and some negatively. They are answered on 
a four-point scale ranging from 1 (none or a little 
of the time) to 4 (most or all of the time). A cut-
off  of 46 was used to ascertain at least moderate 
symptoms of anxiety.
Patients signed an informed consent form and vol-
untarily took part in this research.
STATISTICAL ANALYSIS
Statistical analysis of differences in the frequency of 
categorical variables was performed by means of odds-
ratio using a 95% confidence interval. Comparisons be-
tween means were performed by means of the Student’s 
t-test for independent samples. A logistic regression 
model was run to evaluate the differences between epi-
leptic patients with BHS score ≥ 9 vs those with a BHS 
score < 9. BDI depression scores were split ≤ 9 vs > 9 
and SAS anxiety scores were split < 46 vs ≥ 46. 
Values were expressed as mean ± S.D. The 5% lev-
el of statistical significance was used. All statistical 
analyses were performed using SPSS (version13.0) 
software (Tables 2 and 3).
RESULTS
Twenty-six percent of the epileptic patients had 
scores ≥ 9 on the BHS, suggesting that they should 
be evaluated for suicidal inclinations. These patients 
were significantly older by about 9 years and were 
three to four times more likely to have higher levels 
of depression and anxiety. They did not differ in sex, 
age of onset of epilepsy or in their responsiveness 
to medication. In the logistic regression analysis, a 
hopelessness score ≥ 9 was predicted by BDI depres-
sion scores and SAS anxiety scores after controlling 
for sex, age and response to epileptic drugs.
Table 1 | Characteristics of epileptic patients (n. = 103)
Variable Mean ± SD Range
Age 41.6 ± 14.1 19-78
Age of seizure onset 23.1 ± 16.6 0-72
Beck hopelessness scale (BHS) 6.4 ± 3.8 1-17
Zung self-rating anxiety scale (SAS) 37.7 ± 7.9 23-56
Beck depression inventory (BDI) 9.5 ± 8.5 0-38
Table 2 | Comparison between epileptic patients with BHS score ≥ 9 vs those with a score of BHS < 9
Variable Patients with BHS ≥ 9 (n. = 27)
Patients with 
BHS < 9 (n. = 76) p or OR (CI 95%)
Sex (M/F) 8/19 23/53 1.0 (0.4-2.7) 
Age 48.3 ±  14.1 39.3 ±13.4 0.004
Age of seizure onset 27.5 ± 20.1 21.7 ±15.1 ns
Response drugs (y/n) 18/9 56/20 0.7 (0.3-1.8)
BDI (> 9 vs ≤ 9) 18/9 25/51 4.1 (1.6-10.4)
SAS (≥ 46 vs < 46) 9/18 11/65 2.9 (1.1-8.2)
BHS: Beck hopelessness scale; BDI: Beck depression inventory; SAS: Zung self-rating anxiety scale; p: statistical significance.
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DISCUSSION
The present study found that about one-quarter of 
a sample of patients with epilepsy had high levels 
of hopelessness. According to criteria developed by 
Beck et al. [38], these patients are at increased risk 
of engaging in fatal suicidal behavior. Thus, these 
patients should be evaluated for their suicidal poten-
tial and watched carefully while under treatment.
Interestingly, a high level of hopelessness was as-
sociated with high levels of depression in general (in-
cluding components other than the cognitive com-
ponent) and anxiety. The increased level of anxiety 
suggests an energizing factor which may increase the 
likelihood of suicidal acting-out behavior.
Age was also found to be predictive of high levels 
of hopelessness, indicating that older patients with 
epilepsy may be at higher risk of suicidal behavior 
than younger patients. Perhaps, as patients with epi-
lepsy grow older, they become more hopeless about 
their condition and their prospects for the future.
This study has a number of limitations. First of all, 
the nonprobability method of sampling used in our 
study may limit the generalizability of the results. 
Also, the findings, based on diagnostically complex 
and relatively treatment-resistant subjects, may not 
generalize to other groups. Furthermore, by not tak-
ing into account other subtypes of epilepsy, we were 
unable to identify whether any particular subtype of 
epilepsy was associated with higher morbidity and 
suicide risk. However, grouping epilepsies for the 
various subtypes indicates that suicide risk is much 
higher than in the general population [23, 26]. As 
part of an ongoing investigation comprising various 
institutions in Italy, this preliminary report com-
prised patients gathered in three centres which may 
bias the psychometric evaluation of patients. 
A thorough psychiatric investigation, with proper clini-
cal assessment of suicide risk including past suicidal be-
havior, was not conducted as the patients were interviewed 
during their neurological consultations. Interactions be-
tween neurologists and psychiatrists is therefore highly 
recommended for better screening for patients at risk of 
suicide or suffering from psychiatric disorders.
Despite these caveats, this investigation represents 
an important first step in the evaluation and under-
standing of the alarming phenomenon of suicidal risk 
among patients with epilepsy. One important implica-
tion of the present study for public health is the impor-
tance of screening for suicidal risk as well as depression 
and anxiety in this group of patients. Implementation 
of such a procedure will certainly help to prevent sui-
cide (Table 4).
It would be useful in future research to follow up 
samples of this type of patient to see how many and 
which patients do engage in fatal and non-fatal suicid-
al behavior. In addition, since the present sample was 
restricted to patients with temporal lobe epilepsy, it 
would be of interest to extend the study to other types 
of epileptic patients. 
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Table 3 | Logistic regression analysis to evaluate the relation between BHS scores and the evaluation of depression and anxiety 
adjusted for some variables (sex, age and response to epileptic drugs)
B p OR 95% CI 
   Lower Upper
BDI 1.11 0.04 3.05 1.05 8.80
Zung-SAS 0.78 0.22 2.19 0.63 7.64
Response to epileptic drugs (y/n) 0.33 0.55 1.39 0.48 4.05
Age 0.05 0.08 1.05 1.01 1.09
Sex (M/F) 0.13 0.82 1.14 0.36 3.60
B: regressor’s coefficient; p: statistical significance; OR: odds risk; CI:confidence intervals; BHS: Beck hopelessness scale; BDI: Beck depression inventory.
Table 4 | Assessment of suicide risk should be carried out in patients suffering from epilepsy and for those epileptic patients 
who are surgically treated (Adapted from 43)
• Identify the multiple contributing factors
• Conduct a thorough psychiatric examination, identifying risk factors and protective factors and distinguishing risk factors which can be modified 
from those which cannot
• Ask directly about suicide 
• Determine level of suicide risk: low, moderate, high
• Determine treatment setting and plan
• Investigate past and present suicidal ideation, plans, behaviors, intent; methods; hopelessness, anhedonia, anxiety symptoms; reasons for living; 
associated substance use; homicidal ideation
• Warning signs: expressing suicidal feelings or bringing up the topic of suicide; giving away prized possessions, settling affairs, making out a will; 
signs of depression: sad mood, alterations in sleeping/eating patterns; change of behavior (poor work or school performance); risk-taking behaviors; 
increased use of alcohol or drugs; social isolation; developing a specific plan for suicide
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